| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 754735 | Null | 0.0421163101172308 | 0.34834673 |
| NSC 758027 | Null | 0.0421163101172308 | 0.1663745 |
| NSC 758357 | 2-oxo-N-(pyridin-4-yl)-2-(1-tosyl-1H-indol-3-yl)acetamide | 0.0421163101172308 | 0.42854003 |
| NSC 761817 | (Z)-5-methoxy-3-((1-(3,4,5-trimethoxyphenyl)-9H-pyrido[3,4-b]indol-3-yl)methylene)indolin-2-one | 0.0421163101172308 | 0.35036715 |
| NSC 763621 | (Z)-3-((2-(4-(trifluoromethyl)phenyl)-3H-benzo[d]imidazol-5-yl)methylene)indolin-2-one | 0.0421163101172308 | 0.34251613 |
| NSC 122864 | Styrene, 2,6-dichloro-.beta.-nitro- | 0.0430277102950697 | 0.52508748 |
| NSC 140380 | Ethanesulfonic acid, compd. with 4-[[2-chloro-4-(4,6-diamino-2,2-dimethyl-1,3,5-triazin-1(2H)-yl)phenoxy]acetyl]morpholine (1:1) (9CI) (MF2) | 0.0430277102950697 | 0.044284282 |
| NSC 160121 | 1H,5H-Benzo[ij]quinolizine, 2,3,6,7-tetrahydro-9-(octylamino)-, dihydrochloride | 0.0430277102950697 | 0.16562143 |
| NSC 287459 | Cytarabine AY | 0.0430277102950697 | 0.30146011 |
| NSC 295466 | Null | 0.0430277102950697 | 0.32546562 |